Corrigendum: Targeting ACLY Attenuates Tumor Growth and Acquired Cisplatin Resistance in Ovarian Cancer by Inhibiting the PI3K–AKT Pathway and Activating the AMPK–ROS Pathway

Corrigendum: Targeting ACLY Attenuates Tumor Growth and Acquired Cisplatin Resistance in Ovarian Cancer by Inhibiting the PI3K–AKT Pathway and Activating the AMPK–ROS Pathway

Bibliographic Details
Main Authors: Xuan Wei, Juanjuan Shi, Qianhan Lin, Xiaoxue Ma, Yingxin Pang, Hongluan Mao, Rui Li, Wei Lu, Yu Wang, Peishu Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Oncology
Subjects:
ACLY
ovarian cancer
cisplatin resistance
PI3K-AKT pathway
AMPK-ROS pathway
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.742374/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.742374/full

Similar Items